{"doi":"10.3390/ijms22020970","title":"Characteristics and Therapeutic Potential of Human Amnion-Derived Stem Cells","abstract":"<jats:p>Stem cells including embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs) and adult stem cells (ASCs) are able to repair/replace damaged or degenerative tissues and improve functional recovery in experimental model and clinical trials. However, there are still many limitations and unresolved problems regarding stem cell therapy in terms of ethical barriers, immune rejection, tumorigenicity, and cell sources. By reviewing recent literatures and our related works, human amnion-derived stem cells (hADSCs) including human amniotic mesenchymal stem cells (hAMSCs) and human amniotic epithelial stem cells (hAESCs) have shown considerable advantages over other stem cells. In this review, we first described the biological characteristics and advantages of hADSCs, especially for their high pluripotency and immunomodulatory effects. Then, we summarized the therapeutic applications and recent progresses of hADSCs in treating various diseases for preclinical research and clinical trials. In addition, the possible mechanisms and the challenges of hADSCs applications have been also discussed. Finally, we highlighted the properties of hADSCs as a promising source of stem cells for cell therapy and regenerative medicine and pointed out the perspectives for the directions of hADSCs applications clinically.</jats:p>","journal":"International Journal of Molecular Sciences","year":2021,"id":656200,"datarank":0.7143260902196635,"base_score":4.762173934797756,"endowment":4.762173934797756,"self_citation_contribution":0.7143260902196635,"citation_network_contribution":0.0,"self_endowment_contribution":0.7143260902196635,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":116,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1712952,"name":"Qi-Ming Huang","orcid":null,"position":1,"is_corresponding":false},{"id":1712954,"name":"Han-You Wu","orcid":null,"position":2,"is_corresponding":false},{"id":1712955,"name":"Guo-Si-Lang Zuo","orcid":null,"position":3,"is_corresponding":false},{"id":1712957,"name":"Hao-Cheng Gu","orcid":null,"position":4,"is_corresponding":false},{"id":1712960,"name":"Ke-Yu Deng","orcid":null,"position":5,"is_corresponding":false},{"id":639621,"name":"Hong-Bo Xin","orcid":null,"position":6,"is_corresponding":false},{"id":1712950,"name":"Quan-Wen Liu","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Characteristics and Therapeutic Potential of Human Amnion-Derived Stem Cells","abstract":"<jats:p>Stem cells including embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs) and adult stem cells (ASCs) are able to repair/replace damaged or degenerative tissues and improve functional recovery in experimental model and clinical trials. However, there are still many limitations and unresolved problems regarding stem cell therapy in terms of ethical barriers, immune rejection, tumorigenicity, and cell sources. By reviewing recent literatures and our related works, human amnion-derived stem cells (hADSCs) including human amniotic mesenchymal stem cells (hAMSCs) and human amniotic epithelial stem cells (hAESCs) have shown considerable advantages over other stem cells. In this review, we first described the biological characteristics and advantages of hADSCs, especially for their high pluripotency and immunomodulatory effects. Then, we summarized the therapeutic applications and recent progresses of hADSCs in treating various diseases for preclinical research and clinical trials. In addition, the possible mechanisms and the challenges of hADSCs applications have been also discussed. Finally, we highlighted the properties of hADSCs as a promising source of stem cells for cell therapy and regenerative medicine and pointed out the perspectives for the directions of hADSCs applications clinically.</jats:p>","is_dataset_classified":null,"base_score":4.762173934797756,"endowment":4.762173934797756,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"33478081","pmcid":"PMC7835733","openalex_id":"https://openalex.org/W3122490491","authors":[],"funders":[{"funder_name":"Jiangxi Provincial Department of Science and Technology","grant_id":"20192BAB205032, 2018ACB21043","title":null},{"funder_name":"National Natural Science Foundation of China","grant_id":"81873659, 81970256, 81760118, 81760140, 91639106","title":null},{"funder_name":"the grant for Jiangxi Provincial Collaborative Innovation Center of Biopharmaceutics and Biotechnolog","grant_id":"2015202004","title":null}],"total_grants":3,"fwci":5.8477,"citation_percentile":0.97538845,"influential_citations":0,"citation_trend":[{"year":2021,"count":13},{"year":2022,"count":18},{"year":2023,"count":23},{"year":2024,"count":25},{"year":2025,"count":29},{"year":2026,"count":7}],"oa_status":"gold","license":"cc-by","oa_locations":[{"url":"https://www.mdpi.com/1422-0067/22/2/970/pdf","host_type":"journal"},{"url":"https://www.mdpi.com/1422-0067/22/2/970/pdf","host_type":"publisher"},{"url":"https://doi.org/10.3390/ijms22020970","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/33478081","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7835733","host_type":"repository"},{"url":"https://doaj.org/article/ee7a044f95cd4961a128888f18e7de62","host_type":"repository"},{"url":"https://dx.doi.org/10.3390/ijms22020970","host_type":"repository"},{"url":"https://europepmc.org/articles/PMC7835733","host_type":"Europe_PMC"},{"url":"https://europepmc.org/articles/PMC7835733?pdf=render","host_type":"Europe_PMC"}],"fields_of_study":["Pluripotent Stem Cells Research","Mesenchymal stem cell research","Tissue Engineering and Regenerative Medicine"],"mesh_terms":["Amnion","Cell Differentiation","Epithelial Cells","Humans","Regenerative Medicine","Mesenchymal Stem Cell Transplantation","Mesenchymal Stem Cells","Cell- and Tissue-Based Therapy"],"keywords":["Stem cell","Induced pluripotent stem cell","Amnion","Embryonic stem cell","Regenerative medicine","Amniotic epithelial cells","Cell therapy","Mesenchymal stem cell","Adult stem cell","Stem-cell therapy","Biology","Clinical uses of mesenchymal stem cells","Medicine","Cancer research","Immunology","Cell biology","Amniotic membrane","Human Amniotic Epithelial Stem Cells","Human Amniotic Mesenchymal Stem Cells","Human Amniotic Stem Cells"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[{"name":"nct"},{"name":"doi"}],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-11T20:07:08.815403Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}